Wilson, Steven K. https://orcid.org/0000-0002-9342-5475
Mulcahy, John J.
Pearce, Ian
Modgil, Vaibhav
Hamdan, Mohammad
Chung, Eric https://orcid.org/0000-0003-3373-3668
Love, Christopher
Kirkik, Duygu https://orcid.org/0000-0003-1417-6915
Osmonov, Daniar https://orcid.org/0000-0003-4963-9158
Article History
Received: 25 November 2024
Revised: 5 March 2025
Accepted: 26 March 2025
First Online: 25 April 2025
Competing interests
: The authors declare the following competing interests. SW serves as a consultant for International Medical Devices, Rigicon, and Uramix. JM is a consultant for Boston Scientific. MH has consulting roles with Coloplast, Boston Scientific, and Rigicon. CL is a consultant for Coloplast and Rigicon. VM and IP both serve as consultants for Boston Scientific, Coloplast, and Rigicon. DK is employed as a Clinical Research Officer for Rigicon. DO is a consultant for Coloplast and Rigicon. EC declares no competing interests. These disclosures do not influence the integrity or objectivity of the work presented in this manuscript.